Singapore-listed consumer healthcare corporation Cordlife Group is seeking to increase its presence in Malaysia’s healthcare sector by offering to purchase shares of associated firm StemLife Berhad in a deal valued at S$24.4 million ($17.1 million).
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
